Jan Mattsson - 19 Jan 2023 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
Chief Scientific Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Jan 2023
Net transactions value
-$135,254
Form type
4
Filing time
20 Jan 2023, 15:05:24 UTC
Previous filing
25 Oct 2022
Next filing
23 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $135,254 -3,088 -5.3% $43.80 54,671 19 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 35,377 shares of common stock and 19,294 restricted stock units.